The interactions between inflammation and coagulation

British Journal of Haematology

Volumn 131, Issue 4, 2005, Pages 417-430

  Esmon, Charles T ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Inflammation; Protein C pathway; Sepsis; Thrombosis; Vascular biology

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBIN; AUTACOID; CD1 ANTIGEN; COMPLEMENT; CYTOKINE; FIBRIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLASMIN; PLASMINOGEN; PROTEIN C; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BLOOD CLOTTING; BLOOD VESSEL INJURY; BYPASS SURGERY; CARDIOVASCULAR INFLAMMATION; CELL FUNCTION; CLINICAL TRIAL; COMPLEMENT ACTIVATION; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENTERITIS; FIBRINOLYSIS; FULMINATING PURPURA; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; TERMINAL DISEASE; THROMBOSIS; BLOOD; INFLAMMATION; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; BLOOD COAGULATION; FIBRINOLYSIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; THROMBOSIS;

EID: 33644801469     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05753.x     Document Type: Review

References (128)

1. Abeyama K. Stern D.M. Ito Y. Kawahara K. Yoshimoto Y. Tanaka M. Uchimura T. Ida N. Yamazaki Y. Yamada S. Yamamoto Y. Yamamoto H. Iino S. Taniguchi N. Maruyama I. ( 2005) The N-terminal domain of thrombomodulin sequesters high mobility group-B1 protein, a novel anti-inflammatory mechanism. Journal of Clinical Investigation, 115, 1267 1274.
2. Abraham E. Reinhart K. Opal S. Demeyer I. Doig C. Rodriguez A.L. Beale R. Svoboda P. Laterre P.F. Simon S. Light B. Spapen H. Stone J. Seibert A. Peckelsen C. De Deyne C. Postier R. Pettilä V. Sprung C.L. Artigas A. Percell S.R. Shu V. Zwingelstein C. Tobias J. Poole L. Stolzenbach J.C. Creasey A.A. ( 2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. Journal of the American Medical Association, 290, 238 247.
3. Altieri D.C. Edgington T.S. ( 1988) The saturable high affinity association of Factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. Journal of Biological Chemistry, 263, 7007 7015.
4. Altieri D.C. Morrissey J.H. Edgington T.S. ( 1988) Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: An alternative initiation of the coagulation protease cascade. Proceedings of the National Academy of Sciences United States of America, 85, 7462 7466.
5. Altieri D.C. Etingin O.R. Fair D.S. Brunck T.K. Geltosky J.E. Hajjar D.P. Edgington T.S. ( 1991) Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors. Science, 254, 1200 1202.
6. 3 integrin-dependent mechanism. Nature Medicine, 8, 247 252.
7. Baglin T.P. Carrell R.W. Church F.C. Esmon C.T. Huntington J.A. ( 2002) Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proceedings of the National Academy of Sciences United States of America, 99, 11079 11084.
8. Bajzar L. Morser J. Nesheim M. ( 1996) TAFI, or Plasma Procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. Journal of Biological Chemistry, 271, 16603 16608.
9. Ballantyne C.M. Hoogeveen R.C. Bang H. Coresh J. Folsom A.R. Heiss G. Sharrett A.R. ( 2004) Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation, 109, 837 842.
10. Bernard G.R. Vincent J.L. Laterre P.F. LaRosa S.P. Dhainaut J.F. Lopez-Rodriguez A. Steingrub J.S. Garber G.E. Helterbrand J.D. Ely E.W. Fisher C.J. ( 2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine, 344, 699 709.
11. Bernardo A. Ball C. Nolasco L. Moake J.F. Dpmg J. ( 2004) Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood, 104, 100 106.
12. Blasi F. Carmeliet P. ( 2002) uPAR: a versatile signaling orchestrator. Nature Review Molecular Cellular Biology, 3, 932 943.
13. Boffa M.B. Hamill J.D. Maret D. Scott M.L. Nesheim M.E. Koschinsky M.L. ( 2003) Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells. Journal of Biological Chemistry, 278, 9250 9257.
14. Broze G.J. Jr. Warren L.A. Novotny W.F. Higuchi D.A. Girard J.J. Miletich J.P. ( 1988) The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood, 71, 335 343.
15. Burstein S.A. ( 1997) Cytokines, platelet production and hemostasis. Platelets, 8, 93 104.
16. Camerer E. Rottingen J.A. Gjernes E. Larsen K. Skartlien A.H. Iversen J.G. Prydz H. ( 1999) Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. Journal of Biological Chemistry, 274, 32225 32233.
17. Campbell W. Okada N. Okada H. ( 2001) Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis. Immunological Reviews, 180, 162 167.
18. Cermak J. Key N.S. Bach R.R. Balla J. Jacob H.S. Vercellotti G.M. ( 1993) C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood, 82, 513 520.
19. Conway E.M. Rosenberg R.D. ( 1988) Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Molecular and Cellular Biology, 8, 5588 5592.
20. Conway E.M. Pollefeyt S. Collen D. Steiner-Mosonyi M. ( 1997) The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis. Blood, 89, 652 661.
21. Conway E.M. Van de Wouwer M. Pollefeyt S. Jurk K. Van Aken H. De Vriese A. Weitz J.I. Weiler H. Hellings P.W. Schaeffer P. Herbert J.-M. Collen D. Theilmeier G. ( 2002) The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor κB and mitogen-activated protein kinase pathways. Journal of Experimental Medicine, 196, 565 577.
22. Creasey A.A. Chang A.C. Fiegen L. Wun T.-C. Taylor F.B. Jr. Hinshaw L.B. ( 1993) Tissue factor pathway inhibitor (TFPI) reduces mortality from Escherichia coli septic shock. Journal of Clinical Investigation, 91, 2850 2860.
23. Cunningham M.A. Romas P. Hutchinson P. Holdsworth S.R. Tipping P.G. ( 1999) Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood, 94, 3413 3420.
24. Dahlbäck B. ( 1986) Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. Journal of Biological Chemistry, 261, 12022 12027.
25. Dahlbäck B. Frohm B. Nelsestuen G. ( 1990) High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium. Journal of Biological Chemistry, 265, 16082 16087.
26. Danenberg H.D. Szalai A.J. Swaminathan R.V. Peng L. Chen Z. Seifert P. Fay W.P. Simon D.I. Edelman E.R. ( 2003) Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation, 108, 512 515.
27. Day S.M. Reeve J.L. Pedersen B. Farris D.M. Myers D.D. Im M. Wakefield T.W. Mackman N. Fay W.P. ( 2005) Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood, 105, 192 198.
28. Devaraj S. Xu D.Y. Jialal I. ( 2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 107, 398 404.
29. Dreyfus M. Magny J.F. Bridey F. Schwarz H.P. Planché C. Dehan M. Tchernia G. ( 1991) Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. New England Journal of Medicine, 325, 1565 1568.
30. Edgington T.S. Mackman N. Brand K. Ruf W. ( 1991) The structural biology of expression and function of tissue factor. Thrombosis and Haemostasis, 66, 67 79.
31. Emerson T.E. Fournel M.A. Redens T.B. Taylor F.B. III.. ( 1989) Efficacy of antithrombin-III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. American Journal of Medicine, 87, 27S 33S.
32. Esmon C.T. ( 1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. Journal of Biological Chemistry, 264, 4743 4746.
33. Esmon C.T. ( 2000) Regulation of blood coagulation. Biochimica et Biophysica Acta, 1477, 349 360.
34. Esmon C.T. ( 2003) The Protein C Pathway. Chest, 124, 26 32.
35. Esmon C.T. ( 2004) Why do animal models (sometimes) fail to mimic human sepsis Critical Care Medicine, 32 ( 5 Suppl. S219 S222.
36. Esmon C.T. ( 2005) Is APC activation of endothelial cell PAR1 important in severe sepsis? No. Journal of Thrombosis and Haemostasis, 3, 1910 1911.
37. Faioni E.M. Ferrero S. Fontana G. Gianelli U. Ciulla M.M. Vecchi M. Saibeni S. Biguzzi E. Cordani N. Franchi F. Bosari S. Cattaneo M. ( 2004) Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Critical Care Medicine, 32, S266 S270.
38. Falati S. Liu Q. Gross P. Merrill-Skoloff G. Chou J. Vandendries E. Celi A. Croce K. Furie B.C. Furie B. ( 2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein 1 and platelet P-selectin. Journal of Experimental Medicine, 197, 1585 1598.
39. Faust S.N. Levin M. Harrison O.B. Goldin R.D. Lockhart M.S. Kondaveeti S. Laszik Z. Esmon C.T. Heyderman R.S. ( 2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. New England Journal of Medicine, 345, 408 416.
40. Feistritzer C. Riewald M. ( 2005) Endothelial barrier protection by activated protein C through PAR1-dependent sphinosine 1-phospate receptor-1 crossactivation. Blood, 105, 3178 3184.
41. Finigan J.H. Dudek S.M. Singleton P.A. Chiang E.T. Jacobson J.R. Camp S.M. Ye S.Q. Garcia J.G. ( 2005) Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. Journal of Biological Chemistry, 280, 17286 17293.
42. Fisher C.J. Yan S.B. ( 2000) Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Critical Care Medicine, 28, S49 S56.
43. Fukudome K. Esmon C.T. ( 1994) Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. Journal of Biological Chemistry, 269, 26486 26491.
44. Giesen P.L.A. Rauch U. Bohrmann B. Kling D. Roqué M. Fallon J.T. Badimon J.J. Himber J. Riederer M.A. Nemerson Y. ( 1999) Blood-borne tissue factor: another view of thrombosis. Proceedings of the National Academy of Sciences United States of America, 96, 2311 2315.
45. Glaser C.B. Morser J. Clarke J.H. Blasko E. McLean K. Kuhn I. Chang R.-J. Lin J.-H. Vilander L. Andrews W.H. Light D.R. ( 1992) Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. Journal of Clinical Investigation, 90, 2565 2573.
46. Gu J.-M. Crawley J.T.B. Ferrell G. Zhang F. Li W. Esmon N.L. Esmon C.T. ( 2002) Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. Journal of Biological Chemistry, 277, 43335 43343.
47. Han K.H. Hong K.H. Park J.H. Ko J. Kang D.H. Choi K.J. Hong M.K. Park S.W. Park S.J. ( 2004) C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation, 109, 2566 2571.
48. Hancock W.W. Grey S.T. Hau L. Akalin E. Orthner C. Sayegh M.H. Salem H.H. ( 1995) Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation, 60, 1525 1532.
49. Hantgan R.R. Simpson-Haidaris P.J. Francis C.W. Marder V.J. ( 2001) Fibrinogen structure and physiology. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice ( ed. by R.W. Colman J. Hirsh V.J. Marder A.W. Clowes J.N. George pp. 203 232. Lippincott Williams and Wilkins, Philadelphia, PA.
50. He X. Dahlbäck B. ( 1994) Rabbit plasma, unlike its human counterpart, contains no complex between protein S and C4b-binding protein. Thrombosis and Haemostasis, 7, 446 451.
51. Henn V. Slupsky J.R. Gräfe M. Anagnostopoulos I. Förster R. Müller-Berghaus G. Kroczek R.A. ( 1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 391, 591 594.
52. Hong S. Scherer D.C. Singh N. Mendiratta S.K. Serizawa I. Koezuka Y. Van Kaer L. ( 1999) Lipid antigen presentation in the immune system learned from CD1d knockout mice. Immunological Reviews, 169, 31 44.
53. Huang Z.-F. Higuchi D. Lasky N. Broze G.J. Jr. ( 1997) Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood, 90, 944 951.
54. Huang H.-C. Shi G.-Y. Jiang S.-J. Shi C.-S. Wu C.-M. Yang H.-Y. Wu H.-L. ( 2003) Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. Journal of Biological Chemistry, 278, 46750 46759.
55. Hurtado V. Montes R. Gris J.-C. Bertolaccini M.L. Alonso A. Martínez-González M.A. Khamashta M.A. Fukudome K. Lane D.A. Hermida J. ( 2004) Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood, 104, 1369 1374.
56. Isermann B. Hendrickson S.B. Hutley K. Wing M. Weiler H. ( 2001) Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development, 128, 827 838.
57. Ishiguro K. Kojima T. Kadomatsu K. Nakayama Y. Takagi A. Suzuki M. Takeda N. Ito M. Yamamoto K. Matsushita T. Kusugami K. Muramatsu T. Saito H. ( 2000) Complete antithrombin deficiency in mice results in embryonic lethality. Journal of Clinical Investigation, 106, 873 878.
58. Iwanaga S. Kawabata S. Muta T. ( 1998) New types of clotting factors and defense molecules found in horseshoe crab hemolymph: Their structures and functions. Journal of Biochemistry, 123, 1 15.
59. Jalbert L.R. Rosen E.D. Moons L. Chan J.C. Carmeliet P. Collen D. Castellino F.J. ( 1998) Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. Journal of Clinical Investigation, 102, 1481 1488.
60. Joyce D.E. Gelbert L. Ciaccia A. DeHoff B. Grinnell B.W. ( 2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. Journal of Biological Chemistry, 276, 11199 11203.
61. Kaneider N.C. Egger P. Dunzendorfer S. Wiedermann C.J. ( 2001) Syndecan-4 as antithrombin receptor of human neutrophils. Biochemical and Biophysical Research Communications, 287, 42 46.
62. Kim A.Y. Walinsky P.L. Kolodgie F.D. Bian C. Sperry J.L. Derning C.B. Peck E.A. Shake J.G. Ang G.B. Sohn R.H. Esmon C.T. Virmani R. Stuart R.S. Rade J.J. ( 2002) Early loss of thrombomodulin expression impairs vein graft thromboresistance: implications for vein graft failure. Circulation Research, 90, 205 212.
63. Klein N.J. Shennan G.I. Heyderman R.S. Levin M. ( 1992) Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. Journal of Cell Science, 102, 821 832.
64. Klein N.J. Ison C.A. Peakman M. Levin M. Hammerschmidt S. Frosch M. Heyderman R.S. ( 1996) The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. Journal of Infectious Diseases, 173, 172 179.
65. Kurosawa S. Esmon C.T. Stearns-Kurosawa D.J. ( 2000) The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CDIIb/CDI8. Journal of Immunology, 165, 4697 4703.
66. Lane D.A. Mannucci P.M. Bauer K.A. Bertina R.M. Bochkov N.P. Boulyjenkov V. Chandy M. Dahlbäck B. Ginter E.K. Miletich J.P. Rosendaal F.R. Seligsohn U. ( 1996a) Inherited thrombophilia: part 1. Thrombosis and Haemostasis, 76, 651 662.
67. Lane D.A. Mannucci P.M. Bauer K.A. Bertina R.M. Bochkov N.P. Boulyjenkov V. Chandy M. Dahlbäck B. Ginter E.K. Miletich J.P. Rosendaal F.R. Seligsohn U. ( 1996b) Inherited thrombophilia: part 2. Thrombosis and Haemostasis, 76, 824 834.
68. Laszik Z.G. Zhou X.J. Ferrell G.L. Silva F.G. Esmon C.T. ( 2001) Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. American Journal of Pathology, 159, 797 802.
69. Levi M. ten Cate H. ( 1999) Disseminated intravascular coagulation. New England Journal of Medicine, 341, 586 592.
70. Liaw P.C.Y. Ferrell G. Esmon C.T. ( 2003) A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation. Journal of Thrombosis and Haemostasis, 1, 662 670.
71. Lindmark E. Tenno T. Siegbahn A. ( 2000) Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 2322 2328.
72. Liu L.-W. Vu T.-K.H. Esmon C.T. Coughlin S.R. ( 1991) The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. Journal of Biological Chemistry, 266, 16977 16980.
73. Loike J.D. El Khoury J. Cao L. Richards C.P. Rascoff H. Mandeville J.T.H. Maxfield F.R. Silverstein S.C. ( 1995) Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine. Journal of Experimental Medicine, 181, 1763 1772.
74. Loskutoff D.J. Curriden S.A. Hu G. Deng G. ( 1999) Regulation of cell adhesion by PAI-1. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 107, 54 61.
75. Maradit-Kremers H. Crowson C.S. Nicola P.J. Ballman K.V. Roger V.L. Jacobsen S.J. Gabriel S.E. ( 2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis and Rheumatism, 52, 402 411.
76. Marcum J.A. Rosenberg R.D. ( 1984) Anticoagulantly active heparin-like molecules from the vascular tissue. Biochemistry, 23, 1730 1737.
77. Masamura K. Oida K. Kanehara H. Suzuki J. Horie S. Ishii H. Miyamori I. ( 2003) Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family. Arteriosclerosis, Thrombosis and Vascular Biology, 23, 512 517.
78. Miller D.L. Yaron R. Yellin M.J. ( 1998) CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. Journal of Leukocyte Biology, 63, 373 379.
79. Moody D.B. Ulrichs T. Mühlecker W. Young D.C. Gurcha S.S. Grant E. Rosat J.-P. Brenner M.B. Costello C.E. Besra G.S. Porcelli S.A. ( 2000) CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature, 404, 884 888.
80. Murphy C. Livingstone W.J. White B. Jeffries C. Smith O.P. ( 2001) Activated protein C inhibits upregulation of both tissue factor and TNFα in endotoxin stimulated monocytes (Abstract). Thrombosis and Haemostasis, July ( Suppl. P509.
81. Myles T. Nishimura T. Yun T.H. Nagashima M. Morser J. Patterson A.J. Pearl R.G. Leung L.L.K. ( 2003) Thrombin activatable fibrinolysis inhibitor: a potential regulator of vascular inflammation. Journal of Biological Chemistry, 278, 51059 51067.
82. Nagashima M. Yin Z.-F. Broze G.J. Jr. Morser J. ( 2002) Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice. Frontiers in Bioscience, 7, d556 d568.
83. Neuenschwander P.F. Fiore M.M. Morrissey J.H. ( 1993) Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes: implications of a two-dimensional enzyme kinetic mechanism. Journal of Biological Chemistry, 268, 21489 21492.
84. Nystedt S. Ramakrishnan V. Sundelin J. ( 1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells: comparison with the thrombin receptor. Journal of Biological Chemistry, 271, 14910 14915.
85. Oelschläger C. Römisch J. Staubitz A. Stauss H. Leithäuser B. Tillmanns H. Hölschermann H. ( 2002) Antithrombin III inhibits nuclear factor (kappa)B activation in human monocytes and vascular endothelial cells. Blood, 99, 4015 4020.
86. Oganesyan V. Oganesyan N. Terzyan S. Qu D. Dauter Z. Esmon N.L. Esmon C.T. ( 2002) The crystal structure of the endothelial protein C receptor and a bound phospholipid. Journal of Biological Chemistry, 277, 24851 24854.
87. Okajima K. ( 2001) Regulation of inflammatory responses by natural anticoagulants. Immunological Reviews, 184, 258 274.
88. Oliver J.A. Monroe D.M. Church F.C. Roberts H.R. Hoffman M. ( 2002) Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood, 100, 539 546.
89. Opal S.M. ( 2000) Therapeutic rationale for antithrombin III in sepsis. Critical Care Medicine, 28, S34 S37.
90. Ostrovsky L. Woodman R.C. Payne D. Teoh D. Kubes P. ( 1997) Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation, 96, 2302 2310.
91. Pabinger I. Brucker S. Kyrle P.A. Schneider B. Korninger H.C. Niessner H. Lechner K. ( 1992) Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagulation and Fibrinolysis, 3, 547 553.
92. Palabrica T. Lobb R. Furie B.C. Aronovitz M. Benjamin C. Hsu Y.M. Sajer S.A. Furie B. ( 1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature, 359, 848 851.
93. Parry G.C.N. Mackman N. ( 1998) NF- 6B mediated transcription in human monocytic cells and endothelial cells. Trends in Cardiovascular Medicine, 8, 138 142.
94. Paul A. Ko K.W. Li L. Yechoor V. McCrory M.A. Szalai A.J. Chan L. ( 2004) C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 109, 647 655.
95. Pendurthi U.R. Alok D. Rao L.V.M. ( 1997) Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proceedings of the National Academy of Sciences United States of America, 94, 12598 12603.
96. Pixley R.A. De La Cadena R. Page J.D. Kaufman N. Wyshock E.G. Chang A. Taylor F.B. Jr. Colman R.W. ( 1993) The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. Journal of Clinical Investigation, 91, 61 68.
97. Rauch U. Bonderman D. Bohrmann B. Badimon J.J. Himber J. Riederer M.A. Nemerson Y. ( 2000) Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood, 96, 170 175.
98. Rezaie A.R. ( 1998) Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa. Journal of Biology, 273, 16824 16827.
99. Rezaie A.R. Cooper S.T. Church F.C. Esmon C.T. ( 1995) Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. Journal of Biological Chemistry, 270, 25336 25339.
100. Riewald M. Petrovan R.J. Donner A. Mueller B.M. Ruf W. ( 2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science, 296, 1880 1882.
101. Rijneveld A.W. Levi M. Florquin S. Speelman P. Carmeliet P. Van Der P.T. ( 2002) Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. Journal of Immunology, 168, 3507 3511.
102. Rivard G.E. David M. Farrell C. Schwarz H.P. ( 1995) Treatment of purpura fulminans in meningococcemia with protein C concentrate. The Journal of Pediatrics, 126, 646 652.
103. Robson S.C. Saunders R. Kirsch R.E. ( 1990) Monocyte-macrophage release of IL-1 is inhibited by type-1 plasminogen activator inhibitors. Journal of Clinical Immunology, 33, 83 90.
104. Rosenberg R.D. ( 1987) Regulation of the Hemostatic Mechanism. In: The Molecular Basis of Blood Diseases ( ed. by G. Stamatoyannopoulos A.W. Nienhuis P. Leder P.W. Majerus pp. 534 574. W.B. Saunders Co., Philadelphia, PA.
105. Shibata M. Kumar S.R. Amar A. Fernandez J.A. Hofman F. Griffin J.H. Zlokovic B.V. ( 2001) Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation, 103, 1799 1805.
106. Shu F. Kobayashi H. Fukudome K. Tsuneyoshi N. Kimoto M. Terao T. ( 2000) Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Letters, 477, 208 212.
107. Sims P.J. Faioni E.M. Wiedmer T. Shattil S.J. ( 1988) Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. Journal of Biological Chemistry, 263, 18205 18212.
108. Sims P.J. Wiedmer T. Esmon C.T. Weiss H.J. Shattil S.J. ( 1989) Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott Syndrome: an isolated defect in platelet procoagulant activity. Journal of Biological Chemistry, 264, 17049 17057.
109. Solymoss S. Tucker M.M. Tracy P.B. ( 1988) Kinetics of inactivation of membrane-bound factor Va by activated protein C. Journal of Biological Chemistry, 263, 14884 14890.
110. Souter P.J. Thomas S. Hubbard A.R. Poole S. Romisch J. Gray E. ( 2001) Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Critical Care Medice, 29, 134 139.
111. Sturn D.H. Kaneider N.C. Feistritzer C. Djanani A. Fukudome K. Wiedermann C.J. ( 2003) Expression and function of the endothelial protein C receptor in human neutrophils. Blood, 102, 1499 1505.
112. Szaba F.M. Smiley S.T. ( 2002) Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood, 99, 1053 1059.
113. Takano S. Kimura S. Ohdama S. Aoki N. ( 1990) Plasma thrombomodulin in health and diseases. Blood, 76, 2024 2029.
114. Taylor F.B. Jr. Chang A. Esmon C.T. D'Angelo A. Vigano-D'Angelo S. Blick K.E. ( 1987) Protein C prevents the coagulopathic and lethal effects of E. coli infusion in the baboon. Journal of Clinical Investigation, 79, 918 925.
115. Tracey K.J. ( 2002) The inflammatory reflex. Nature, 420, 853 859.
116. Wang W. Nagashima M. Schneider M. Morser J. Nesheim M. ( 2000) Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. Journal of Biological Chemistry, 275, 22942 22947.
117. Warren B.L. Eid A. Singer P. Pillay S.S. Carl P. Novak I. Chalupa P. Atherstone A. Penzes I. Kubler A. Knaub S. Keinecke H.O. Heinrichs H. Schindel F. Juers M. Bone R.C. Opal S.M. ( 2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. Journal of the American Medical Association, 286, 1869 1878.
118. Waugh J.M. Yuksel E. Li J. Kuo M.D. Kattash M. Saxena R. Geske R. Thung S.N. Shenaq S.M. Woo S.L. ( 1999) Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circulation Research, 84, 84 92.
119. Waugh J.M. Li-Hawkins J. Yuksel E. Kuo M.D. Cifra P.N. Hilfiker P.R. Geske R. Chawla M. Thomas J. Shenaq S.M. Dake M.D. Woo S.L. ( 2000) Thrombomodulin overexpression to limit neointima formation. Circulation, 102, 332 337.
120. Weiler-Guettler H. Christie P.D. Beeler D.L. Healy A.M. Hancock W.W. Rayburn H. Edelberg J.M. Rosenberg R.D. ( 1998) A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. Journal of Clinical Investigation, 101, 1983 1991.
121. White B. Livingstone W. Murphy C. Hodgson A. Rafferty M. Smith O.P. ( 2000a) An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood, 96, 3719 3724.
122. White B. Schmidt M. Murphy C. Livingstone W. O'Toole D. Lawler M. O'Neill L. Kelleher D. Schwarz H.P. Smith O.P. ( 2000b) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. British Journal of Haematology, 110, 130 134.
123. Wolbink G.-J. Bossink A.W.J. Groeneveld A.B.J. DeGroot M.C.M. Thijs L.G. Hack C.E. ( 1998) Complement activation in patients with sepsis is in part mediated by C-reactive protein. The Journal of Infectious Diseases, 177, 81 87.
124. Yamauchi T. Umeda F. Inoguchi T. Nawata H. ( 1989) Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochemical and Biophysical Research Communications, 163, 1404 1411.
125. Ye J. Liu L.-W. Esmon C.T. Johnson A.E. ( 1992) The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion exosite of thrombin and alter its specificity. Journal of Biological Chemistry, 267, 11023 11028.
126. Ye X. Fukudome K. Tsuneyoshi N. Satoh T. Tokunaga O. Sugawara K. Mizokami H. Kimoto M. ( 1999) The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. Biochemical and Biophysical Research Communications, 259, 671 677.
127. Yuksel M. Okajima K. Uchiba M. Horiuchi S. Okabe H. ( 2002) Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-α production by inhibiting activation of both nuclear factor-(kappa)B and activator protein-1 in human monocytes. Thrombosis and Haemostasis, 88, 267 273.
128. Zwaal R.F.A. Bevers E.M. Comfurius P. Rosing J. Tilly R.H.J. Verhallen P.F.J. ( 1989) Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Molecular and Cellular Biochemistry, 91, 23 31.